Ophthalmoscope Market Size & Share, by Application (Glaucoma, Retinal Tear, Diabetes); End-user (Hospitals, Eye Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3999
  • Published Date: Aug 04, 2023
  • Report Format: PDF, PPT


Companies Dominating the Ophthalmoscope Landscape

    • Medline Industries, LP
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Eli Lilly and Company
    • Bausch & Lomb Incorporated
    • Sun Pharmaceutical Industries Ltd.
    • Novartis AG
    • Sanofi-aventis Groupe
    • Abbott Laboratories
    • Merck & Co., Inc.
    • Siemens Healthcare GmbH
    • Pfizer Inc.

Browse Key Market Insights with Data Illustration:


In The News

  • Bausch & Lomb Incorporated introduced TotalVisc Viscoelastic System and the StableVisc cohesive ophthalmic viscosurgical device (OVD) with special benefits intended to guarantee the best surgical results for patients.  StableVisc aids in maintaining room in the anterior chamber of the eye, whereas TotalVisc Viscoelastic System, guards the ocular tissue during surgery.
  • Novartis AG acquired Kedalion Therapeutics and its AcuStream technology that might help with accurate dosage and administration of several topical ophthalmic drugs to the eye, and to meet unmet patient needs in front-of-eye disorders.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3999
  • Published Date: Aug 04, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising cases of ocular diseases such as glaucoma, corneal opacification, and others are the major factors driving the market growth.

The market size of ophthalmoscope is anticipated to attain a CAGR of ~4% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Eli Lilly and Company, Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc, and others.

The diabetes segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying